{
    "hands_on_practices": [
        {
            "introduction": "Before we can trust an effect estimate from a propensity score analysis, we must verify that the method successfully balanced the baseline covariates between treatment groups. This exercise focuses on the most widely used metric for this purpose, the Standardized Mean Difference (SMD). Mastering its definition and conventional thresholds for what constitutes acceptable balance is the foundational first step in any rigorous observational study using propensity score methods .",
            "id": "4599524",
            "problem": "An observational cohort study in medical data analytics evaluates the effect of a genomic-guided therapy on a continuous baseline covariate $X$ (for example, a biomarker level) between treated and untreated patients after applying propensity score methods. Let $\\bar{X}_{1}$ and $\\bar{X}_{0}$ denote the sample means in the treated and control groups, respectively, and let $s_{1}^{2}$ and $s_{0}^{2}$ denote the corresponding sample variances computed from independent samples of sizes $n_{1}$ and $n_{0}$. The scientific aim is to quantify covariate balance after matching or weighting using a unitless measure derived from first principles that reflects the difference in location relative to a pooled measure of dispersion.\n\nStarting from fundamental definitions of the sample mean and sample variance, and the principle that standardization by a common scale yields a unitless effect size that is comparable across covariates, select the option that correctly specifies the standardized mean difference (Standardized Mean Difference (SMD)) with a pooled standard deviation and states conventional thresholds for acceptable covariate balance after propensity score matching or weighting. When weighting is used (for example, inverse probability of treatment weighting), interpret means and variances as weighted analogs and use the corresponding effective sample sizes in the pooled scale.\n\nWhich option is correct?\n\nA. The SMD is $SMD=\\dfrac{\\bar{X}_{1}-\\bar{X}_{0}}{s_{p}}$ with pooled standard deviation $s_{p}=\\sqrt{\\dfrac{(n_{1}-1)s_{1}^{2}+(n_{0}-1)s_{0}^{2}}{n_{1}+n_{0}-2}}$. For weighted data, replace unweighted means, variances, and counts with their weighted counterparts and effective sample sizes. After propensity score matching or weighting, acceptable balance is typically taken as $\\lvert SMD\\rvert0.1$ across covariates.\n\nB. The SMD is $SMD=\\dfrac{\\bar{X}_{1}-\\bar{X}_{0}}{\\sqrt{s_{1}^{2}+s_{0}^{2}}}$, because this directly aggregates dispersion without degrees-of-freedom weighting. After matching or weighting, acceptable balance is $\\lvert SMD\\rvert0.5$ to reflect a conventional “medium” effect size.\n\nC. The SMD is $SMD=\\dfrac{\\bar{X}_{1}-\\bar{X}_{0}}{s_{0}}$, standardized by the control-group standard deviation alone to avoid treated-group influence. Acceptable balance is $\\lvert SMD\\rvert0.25$ only for stratification on the propensity score, but not for matched or weighted designs.\n\nD. The SMD is $SMD=\\dfrac{\\bar{X}_{1}-\\bar{X}_{0}}{\\bar{X}_{0}}\\times 100\\%$, a percent difference that is invariant to rescaling. Acceptable balance is $\\lvert SMD\\rvert10\\%$ after matching or weighting because this bounds relative bias by $10\\%$ in any unit system.",
            "solution": "The user has requested a meticulous and exacting validation of the problem statement, followed by a first-principles derivation and evaluation of the provided options.\n\n**Problem Validation**\n\n**Step 1: Extract Givens**\n\nThe problem statement provides the following information:\n- The context is an observational cohort study in medical data analytics.\n- The goal is to evaluate the effect of a genomic-guided therapy.\n- The analysis involves a continuous baseline covariate, denoted by $X$.\n- Two groups are compared: treated and untreated (control).\n- $\\bar{X}_{1}$ and $\\bar{X}_{0}$ are the sample means of the covariate $X$ in the treated and control groups, respectively.\n- $s_{1}^{2}$ and $s_{0}^{2}$ are the sample variances of $X$ in the treated and control groups, respectively.\n- $n_{1}$ and $n_{0}$ are the respective sample sizes of the two independent groups.\n- The objective is to quantify covariate balance after applying propensity score methods (matching or weighting).\n- The desired measure must be unitless.\n- This measure must reflect the \"difference in location relative to a pooled measure of dispersion.\"\n- The derivation must start from fundamental definitions and use the principle of standardization by a common scale.\n- The question asks for the correct specification of the standardized mean difference (SMD) with a pooled standard deviation and its conventional thresholds for acceptable balance.\n- For weighted data, means, variances, and counts are to be interpreted as their weighted analogs, using effective sample sizes.\n\n**Step 2: Validate Using Extracted Givens**\n\nThe problem statement is subjected to validation against the specified criteria.\n\n- **Scientifically Grounded**: The problem is scientifically grounded. The concept of the Standardized Mean Difference (SMD) is a cornerstone of meta-analysis and the assessment of covariate balance in observational studies, particularly in the context of propensity score methods. The definitions provided for sample means, variances, and sample sizes are standard in statistics. The scenario described is a common and realistic application in bioinformatics and biostatistics.\n- **Well-Posed**: The problem is well-posed. It asks for a specific, well-defined statistical quantity (the SMD) and the accepted conventions for its use. A unique answer exists within the established literature of the field.\n- **Objective**: The problem is formulated using precise, objective statistical terminology. It does not contain subjective or opinion-based statements.\n\nThe problem does not exhibit any of the listed flaws:\n1.  **Scientific or Factual Unsoundness**: No violations are present. The statistical concepts are standard.\n2.  **Non-Formalizable or Irrelevant**: The problem is directly formalizable and central to the topic of propensity score methods.\n3.  **Incomplete or Contradictory Setup**: The setup is self-contained and sufficient to define the SMD based on the principles outlined.\n4.  **Unrealistic or Infeasible**: The scenario is realistic.\n5.  **Ill-Posed or Poorly Structured**: The question is clear and unambiguous.\n6.  **Pseudo-Profound, Trivial, or Tautological**: The question requires specific knowledge of statistical methodology and its practical application; it is neither trivial nor artificially contrived.\n7.  **Outside Scientific Verifiability**: The definition of SMD and its conventional thresholds are well-documented and verifiable in statistics and epidemiology literature.\n\n**Step 3: Verdict and Action**\n\nThe problem statement is **valid**. The solution process will now proceed.\n\n**Derivation and Solution**\n\nThe task is to derive a unitless measure that quantifies the difference in the mean of a covariate $X$ between two groups, standardized by a pooled measure of dispersion.\n\n1.  **Difference in Location**: The difference in the location of the covariate distribution between the treated and control groups is naturally measured by the difference in their sample means:\n    $$ \\text{Difference} = \\bar{X}_{1} - \\bar{X}_{0} $$\n    This quantity has the same units as the covariate $X$.\n\n2.  **Standardization by a Pooled Measure of Dispersion**: To create a unitless measure that is comparable across different covariates, this difference must be standardized. The problem specifies standardization by a \"pooled measure of dispersion,\" which in this context means a pooled standard deviation that combines the variability from both groups. The standard method for pooling variance from two independent samples, assuming homogeneity of variances, is to compute a weighted average of the individual sample variances, with weights determined by their degrees of freedom ($n_{1}-1$ and $n_{0}-1$).\n\n3.  **Pooled Variance**: The pooled sample variance, denoted $s_{p}^{2}$, is defined as:\n    $$ s_{p}^{2} = \\frac{(n_{1}-1)s_{1}^{2} + (n_{0}-1)s_{0}^{2}}{(n_{1}-1) + (n_{0}-1)} = \\frac{(n_{1}-1)s_{1}^{2} + (n_{0}-1)s_{0}^{2}}{n_{1}+n_{0}-2} $$\n    This formula provides an unbiased estimator of the common population variance $\\sigma^2$ if the variances in the two populations are indeed equal.\n\n4.  **Pooled Standard Deviation**: The pooled standard deviation, $s_{p}$, is the square root of the pooled variance:\n    $$ s_{p} = \\sqrt{\\frac{(n_{1}-1)s_{1}^{2} + (n_{0}-1)s_{0}^{2}}{n_{1}+n_{0}-2}} $$\n\n5.  **Standardized Mean Difference (SMD)**: The SMD is the ratio of the difference in means to the pooled standard deviation:\n    $$ SMD = \\frac{\\bar{X}_{1} - \\bar{X}_{0}}{s_{p}} = \\frac{\\bar{X}_{1} - \\bar{X}_{0}}{\\sqrt{\\frac{(n_{1}-1)s_{1}^{2} + (n_{0}-1)s_{0}^{2}}{n_{1}+n_{0}-2}}} $$\n    This specific formulation is also known as Hedges' g. For propensity score analysis, this general form is used, and in the case of weighted data, the means, variances, and sample sizes are substituted with their weighted or effective counterparts as stated in the problem.\n\n6.  **Conventional Thresholds for Balance**: In the context of propensity score analysis, the SMD is used as a diagnostic to check if the matching, stratification, or weighting procedure has successfully balanced the baseline covariates between the treated and control groups. While different thresholds have been proposed, a value of $\\lvert SMD\\rvert  0.1$ is widely considered to indicate a negligible and acceptable level of imbalance. This threshold is advocated in influential papers and has become a de facto standard in high-quality medical research.\n\n**Option-by-Option Analysis**\n\n**A. The SMD is $SMD=\\dfrac{\\bar{X}_{1}-\\bar{X}_{0}}{s_{p}}$ with pooled standard deviation $s_{p}=\\sqrt{\\dfrac{(n_{1}-1)s_{1}^{2}+(n_{0}-1)s_{0}^{2}}{n_{1}+n_{0}-2}}$. For weighted data, replace unweighted means, variances, and counts with their weighted counterparts and effective sample sizes. After propensity score matching or weighting, acceptable balance is typically taken as $\\lvert SMD\\rvert0.1$ across covariates.**\n\n-   **Formula**: The formula provided for the SMD and the pooled standard deviation $s_{p}$ is the correct, standard definition derived from first principles. The instruction for handling weighted data is also appropriate.\n-   **Threshold**: The threshold $\\lvert SMD\\rvert  0.1$ is the most common and accepted convention for declaring adequate covariate balance after propensity score adjustment.\n-   **Verdict**: **Correct**.\n\n**B. The SMD is $SMD=\\dfrac{\\bar{X}_{1}-\\bar{X}_{0}}{\\sqrt{s_{1}^{2}+s_{0}^{2}}}$, because this directly aggregates dispersion without degrees-of-freedom weighting. After matching or weighting, acceptable balance is $\\lvert SMD\\rvert0.5$ to reflect a conventional “medium” effect size.**\n\n-   **Formula**: The denominator $\\sqrt{s_{1}^{2}+s_{0}^{2}}$ is not a pooled standard deviation. It is the square root of the sum of variances. A pooled estimate should be a form of average, not a sum. This formulation is incorrect for constructing an SMD.\n-   **Threshold**: A threshold of $\\lvert SMD\\rvert  0.5$ corresponds to a \"medium\" effect size in Cohen's classification. This indicates a substantial difference between groups and is far too lenient for a balance diagnostic. An SMD of $0.5$ would signify poor balance.\n-   **Verdict**: **Incorrect**.\n\n**C. The SMD is $SMD=\\dfrac{\\bar{X}_{1}-\\bar{X}_{0}}{s_{0}}$, standardized by the control-group standard deviation alone to avoid treated-group influence. Acceptable balance is $\\lvert SMD\\rvert0.25$ only for stratification on the propensity score, but not for matched or weighted designs.**\n\n-   **Formula**: The formula $SMD=\\dfrac{\\bar{X}_{1}-\\bar{X}_{0}}{s_{0}}$ uses only the control group's standard deviation for standardization. While this is a valid type of SMD (known as Glass's $\\Delta$), it does not use a *pooled* standard deviation as specified in the problem's core principles.\n-   **Threshold**: The claim that the $\\lvert SMD\\rvert  0.25$ threshold applies *only* to stratification is false. Balance thresholds are general guidelines and are not typically restricted to a single type of propensity score method.\n-   **Verdict**: **Incorrect**.\n\n**D. The SMD is $SMD=\\dfrac{\\bar{X}_{1}-\\bar{X}_{0}}{\\bar{X}_{0}}\\times 100\\%$, a percent difference that is invariant to rescaling. Acceptable balance is $\\lvert SMD\\rvert10\\%$ after matching or weighting because this bounds relative bias by $10\\%$ in any unit system.**\n\n-   **Formula**: This is the formula for a relative or percent difference, not a standardized mean difference. The SMD standardizes by a measure of spread (standard deviation), not a measure of central tendency (mean). This measure is highly unstable if the mean $\\bar{X}_{0}$ is close to $0$. It is not the correct tool for this aplication.\n-   **Threshold**: A threshold of $10\\%$ is associated with relative differences, not SMDs. The justification provided is ad-hoc and not grounded in the standard theory of balance diagnostics.\n-   **Verdict**: **Incorrect**.",
            "answer": "$$\\boxed{A}$$"
        },
        {
            "introduction": "Inverse Probability of Treatment Weighting (IPTW) is a powerful method for estimating causal effects, but it can be sensitive to individuals who are atypical for the treatment they received. This practice provides a direct, hands-on calculation of an IPTW estimate, vividly illustrating how a single observation with an extreme weight can dominate the result and inflate its variance . Understanding this phenomenon is crucial for diagnosing issues and building robust propensity score models.",
            "id": "4830875",
            "problem": "Consider an observational cohort study evaluating a binary treatment $A \\in \\{0,1\\}$ and a continuous, dimensionless clinical outcome $Y$ (for example, a standardized symptom reduction score). Assume the standard causal identification conditions hold: consistency, conditional exchangeability (no unmeasured confounding) given covariates $X$, and positivity. The propensity score is defined as $e(X) = \\mathbb{P}(A=1 \\mid X)$, and the estimator of interest is the Inverse Probability of Treatment Weighting (IPTW) estimator for the Average Treatment Effect (ATE), using the Horvitz–Thompson construction.\n\nYou are given a small sample of $n = 6$ patients indexed by $i = 1,2,3,4,5,6$, with treatment indicator $A_i$, outcome $Y_i$, and estimated propensity score $e_i = e(X_i)$ recorded below. One treated patient has an extreme propensity score leading to a large inverse weight. The data are:\n- Patient $1$: $A_1 = 1$, $Y_1 = 1.2$, $e_1 = 0.02$.\n- Patient $2$: $A_2 = 1$, $Y_2 = 0.8$, $e_2 = 0.55$.\n- Patient $3$: $A_3 = 1$, $Y_3 = 1.0$, $e_3 = 0.65$.\n- Patient $4$: $A_4 = 0$, $Y_4 = 0.9$, $e_4 = 0.50$.\n- Patient $5$: $A_5 = 0$, $Y_5 = 1.1$, $e_5 = 0.30$.\n- Patient $6$: $A_6 = 0$, $Y_6 = 0.7$, $e_6 = 0.20$.\n\nTasks:\n- Starting from the definitions of the propensity score and the Average Treatment Effect (ATE), and invoking the stated identification conditions, derive the Horvitz–Thompson IPTW estimator for the ATE in this finite sample. Then, using the provided data, calculate the IPTW point estimate $\\hat{\\tau}_{\\text{IPTW}}$ exactly.\n- Briefly explain, using the contributions from each subject, why a single extreme weight can strongly influence both the point estimate and its variability. As part of this explanation, compute the empirical influence-function contributions for each subject and the corresponding empirical variance of the estimator. You may present the variance numerically without a rounding requirement.\n\nExpress your final $\\hat{\\tau}_{\\text{IPTW}}$ in exact rational form. Do not include any units in your final numerical answer. Define any acronyms the first time they appear (for example, Inverse Probability of Treatment Weighting (IPTW) and Average Treatment Effect (ATE)).",
            "solution": "The problem asks for the derivation and calculation of an Inverse Probability of Treatment Weighting (IPTW) estimator for the Average Treatment Effect (ATE), followed by an analysis of the influence of an extreme weight on the estimate and its variance.\n\nFirst, we define the core concepts. The potential outcome $Y_i(a)$ represents the outcome patient $i$ would have experienced if they received treatment level $a \\in \\{0,1\\}$. The Average Treatment Effect (ATE), denoted by $\\tau$, is the expected difference in potential outcomes:\n$$\n\\tau = \\mathbb{E}[Y(1)] - \\mathbb{E}[Y(0)]\n$$\n\nTo identify $\\tau$ from observational data, we rely on three standard assumptions provided in the problem statement:\n1.  **Consistency**: For every individual $i$, their observed outcome $Y_i$ is equal to their potential outcome corresponding to the treatment they actually received, $A_i$. Formally, $Y_i = A_i Y_i(1) + (1-A_i) Y_i(0)$.\n2.  **Conditional Exchangeability (No Unmeasured Confounding)**: Given the measured covariates $X$, the treatment assignment $A$ is independent of the potential outcomes $\\{Y(0), Y(1)\\}$. Formally, $\\{Y(0), Y(1)\\} \\perp A \\mid X$.\n3.  **Positivity (or Overlap)**: For any set of covariates $X$ present in the population, there is a non-zero probability of receiving either treatment level. Formally, $0  \\mathbb{P}(A=1 \\mid X)  1$. The propensity score is defined as $e(X) = \\mathbb{P}(A=1 \\mid X)$, so this assumption is $0  e(X)  1$.\n\nWe can now derive an expression for $\\tau$ using observable quantities. Let's focus on identifying $\\mathbb{E}[Y(1)]$.\nUsing the law of total expectation, $\\mathbb{E}[Y(1)] = \\mathbb{E}_X[\\mathbb{E}[Y(1) \\mid X]]$.\nBy conditional exchangeability, $\\mathbb{E}[Y(1) \\mid X] = \\mathbb{E}[Y(1) \\mid A=1, X]$.\nBy consistency, $\\mathbb{E}[Y(1) \\mid A=1, X] = \\mathbb{E}[Y \\mid A=1, X]$.\nSo, $\\mathbb{E}[Y(1)] = \\mathbb{E}_X[\\mathbb{E}[Y \\mid A=1, X]]$. A similar derivation holds for $\\mathbb{E}[Y(0)]$.\n\nThe IPTW method uses a different approach to identify these expectations. Consider the quantity $\\frac{A Y}{e(X)}$. Its expectation is:\n$$\n\\mathbb{E}\\left[\\frac{A Y}{e(X)}\\right] = \\mathbb{E}_X\\left[\\mathbb{E}\\left[\\frac{A Y}{e(X)} \\mid X\\right]\\right] = \\mathbb{E}_X\\left[\\frac{1}{e(X)}\\mathbb{E}[A Y \\mid X]\\right]\n$$\nUsing consistency, $A Y = A Y(1)$. So, $\\mathbb{E}[A Y \\mid X] = \\mathbb{E}[A Y(1) \\mid X]$.\nBy conditional exchangeability, $Y(1) \\perp A \\mid X$, so $\\mathbb{E}[A Y(1) \\mid X] = \\mathbb{E}[A \\mid X] \\mathbb{E}[Y(1) \\mid X]$.\nBy definition, $\\mathbb{E}[A \\mid X] = e(X)$.\nSubstituting back, we get:\n$$\n\\mathbb{E}\\left[\\frac{A Y}{e(X)}\\right] = \\mathbb{E}_X\\left[\\frac{1}{e(X)} e(X) \\mathbb{E}[Y(1) \\mid X]\\right] = \\mathbb{E}_X[\\mathbb{E}[Y(1) \\mid X]] = \\mathbb{E}[Y(1)]\n$$\nA parallel derivation for $\\mathbb{E}[Y(0)]$ using the quantity $\\frac{(1-A)Y}{1-e(X)}$ yields:\n$$\n\\mathbb{E}\\left[\\frac{(1-A)Y}{1-e(X)}\\right] = \\mathbb{E}[Y(0)]\n$$\nCombining these results, the ATE can be expressed as:\n$$\n\\tau = \\mathbb{E}\\left[\\frac{A Y}{e(X)} - \\frac{(1-A)Y}{1-e(X)}\\right]\n$$\nThe Horvitz-Thompson IPTW estimator is the finite sample analog of this expectation, obtained by averaging over the sample:\n$$\n\\hat{\\tau}_{\\text{IPTW}} = \\frac{1}{n} \\sum_{i=1}^{n} \\left( \\frac{A_i Y_i}{e_i} - \\frac{(1-A_i)Y_i}{1-e_i} \\right)\n$$\nwhere $n$ is the sample size, and for each patient $i$, $A_i$ is the treatment indicator, $Y_i$ is the outcome, and $e_i$ is the estimated propensity score.\n\nWe now calculate $\\hat{\\tau}_{\\text{IPTW}}$ for the given sample of $n=6$. Let $\\phi_i = \\frac{A_i Y_i}{e_i} - \\frac{(1-A_i)Y_i}{1-e_i}$.\n- Patient 1: $A_1=1, Y_1=1.2, e_1=0.02$. $\\phi_1 = \\frac{1 \\cdot 1.2}{0.02} - 0 = \\frac{1.2}{0.02} = 60$.\n- Patient 2: $A_2=1, Y_2=0.8, e_2=0.55$. $\\phi_2 = \\frac{1 \\cdot 0.8}{0.55} - 0 = \\frac{0.8}{0.55} = \\frac{80}{55} = \\frac{16}{11}$.\n- Patient 3: $A_3=1, Y_3=1.0, e_3=0.65$. $\\phi_3 = \\frac{1 \\cdot 1.0}{0.65} - 0 = \\frac{1.0}{0.65} = \\frac{100}{65} = \\frac{20}{13}$.\n- Patient 4: $A_4=0, Y_4=0.9, e_4=0.50$. $\\phi_4 = 0 - \\frac{1 \\cdot 0.9}{1-0.50} = -\\frac{0.9}{0.5} = -1.8 = -\\frac{9}{5}$.\n- Patient 5: $A_5=0, Y_5=1.1, e_5=0.30$. $\\phi_5 = 0 - \\frac{1 \\cdot 1.1}{1-0.30} = -\\frac{1.1}{0.7} = -\\frac{11}{7}$.\n- Patient 6: $A_6=0, Y_6=0.7, e_6=0.20$. $\\phi_6 = 0 - \\frac{1 \\cdot 0.7}{1-0.20} = -\\frac{0.7}{0.8} = -\\frac{7}{8}$.\n\nThe sum is $\\sum_{i=1}^6 \\phi_i = 60 + \\frac{16}{11} + \\frac{20}{13} - \\frac{9}{5} - \\frac{11}{7} - \\frac{7}{8}$.\nTo sum the fractions, we find a common denominator for $11, 13, 5, 7, 8$, which is $11 \\times 13 \\times 5 \\times 7 \\times 8 = 40040$.\n$$\n\\sum_{i=1}^6 \\phi_i = 60 + \\frac{16 \\cdot 3640}{40040} + \\frac{20 \\cdot 3080}{40040} - \\frac{9 \\cdot 8008}{40040} - \\frac{11 \\cdot 5720}{40040} - \\frac{7 \\cdot 5005}{40040}\n$$\n$$\n\\sum_{i=1}^6 \\phi_i = 60 + \\frac{58240 + 61600 - 72072 - 62920 - 35035}{40040} = 60 + \\frac{119840 - 170027}{40040} = 60 - \\frac{50187}{40040}\n$$\n$$\n\\sum_{i=1}^6 \\phi_i = \\frac{60 \\cdot 40040 - 50187}{40040} = \\frac{2402400 - 50187}{40040} = \\frac{2352213}{40040}\n$$\nNow, we calculate the estimator $\\hat{\\tau}_{\\text{IPTW}}$:\n$$\n\\hat{\\tau}_{\\text{IPTW}} = \\frac{1}{6} \\sum_{i=1}^6 \\phi_i = \\frac{1}{6} \\cdot \\frac{2352213}{40040} = \\frac{2352213}{240240}\n$$\nWe simplify the fraction by dividing the numerator and denominator by their greatest common divisor, which is $3$:\n$$\n\\hat{\\tau}_{\\text{IPTW}} = \\frac{2352213 \\div 3}{240240 \\div 3} = \\frac{784071}{80080}\n$$\nNumerically, this value is approximately $9.79$.\n\nNext, we analyze the influence of the extreme weight. Patient 1 is a treated individual with a very low propensity score, $e_1 = 0.02$. This score implies that, based on their covariates $X_1$, they were very unlikely to receive the treatment. The IPTW estimator compensates for this imbalance by assigning this patient a very large weight, $w_1 = 1/e_1 = 1/0.02 = 50$. The individual contribution of this patient to the unscaled sum is $\\phi_1 = Y_1/e_1 = 1.2/0.02 = 60$.\nThe contributions from the other patients are: $\\phi_2 \\approx 1.45$, $\\phi_3 \\approx 1.54$, $\\phi_4 = -1.8$, $\\phi_5 \\approx -1.57$, and $\\phi_6 = -0.875$. The contribution from Patient 1 ($\\phi_1=60$) is an order of magnitude larger than any other, and it overwhelmingly determines the final estimate. The sum of all contributions is $\\approx 58.75$, and the ATE estimate is this sum divided by $6$, which is $\\approx 9.79$. Patient 1 alone contributes $60/6 = 10$ to this final value. This demonstrates that the IPTW estimator is highly sensitive to subjects with extreme propensity scores (close to $0$ or $1$), as a single observation can dominate the estimate. This sensitivity leads to high variability (large variance) of the estimator.\n\nTo quantify this, we compute the empirical influence-function contributions, $\\hat{\\psi}_i$, for each subject. The influence function of the sample mean of a variable is the variable minus its mean. Here, $\\hat{\\tau}_{\\text{IPTW}}$ is the sample mean of the $\\phi_i$ values, so the empirical influence contribution for subject $i$ is $\\hat{\\psi}_i = \\phi_i - \\hat{\\tau}_{\\text{IPTW}}$.\nUsing $\\hat{\\tau}_{\\text{IPTW}} = 784071/80080 \\approx 9.7911$:\n- $\\hat{\\psi}_1 = 60 - \\frac{784071}{80080} = \\frac{4804800 - 784071}{80080} = \\frac{4020729}{80080} \\approx 50.209$\n- $\\hat{\\psi}_2 = \\frac{16}{11} - \\frac{784071}{80080} = \\frac{116480 - 784071}{80080} = \\frac{-667591}{80080} \\approx -8.337$\n- $\\hat{\\psi}_3 = \\frac{20}{13} - \\frac{784071}{80080} = \\frac{123200 - 784071}{80080} = \\frac{-660871}{80080} \\approx -8.253$\n- $\\hat{\\psi}_4 = -\\frac{9}{5} - \\frac{784071}{80080} = \\frac{-144144 - 784071}{80080} = \\frac{-928215}{80080} \\approx -11.591$\n- $\\hat{\\psi}_5 = -\\frac{11}{7} - \\frac{784071}{80080} = \\frac{-125840 - 784071}{80080} = \\frac{-909911}{80080} \\approx -11.363$\n- $\\hat{\\psi}_6 = -\\frac{7}{8} - \\frac{784071}{80080} = \\frac{-70070 - 784071}{80080} = \\frac{-854141}{80080} \\approx -10.666$\n\nThe empirical variance of the estimator is given by the sample variance of the $\\phi_i$ values divided by $n$, which can be computed from the influence contributions:\n$$\n\\widehat{\\text{Var}}(\\hat{\\tau}_{\\text{IPTW}}) = \\frac{1}{n(n-1)} \\sum_{i=1}^n \\hat{\\psi}_i^2\n$$\nCalculating the sum of squared influence contributions:\n$\\sum \\hat{\\psi}_i^2 \\approx (50.209)^2 + (-8.337)^2 + (-8.253)^2 + (-11.591)^2 + (-11.363)^2 + (-10.666)^2$\n$\\sum \\hat{\\psi}_i^2 \\approx 2520.94 + 69.51 + 68.11 + 134.35 + 129.12 + 113.76 \\approx 3035.79$\nThe variance is:\n$$\n\\widehat{\\text{Var}}(\\hat{\\tau}_{\\text{IPTW}}) = \\frac{3035.79}{6(5)} = \\frac{3035.79}{30} \\approx 101.193\n$$\nThe squared influence of Patient 1, $\\hat{\\psi}_1^2 \\approx 2520.94$, accounts for approximately $2520.94 / 3035.79 \\approx 83\\%$ of the total sum of squares, confirming that the variance of the estimator is overwhelmingly driven by this single influential observation.",
            "answer": "$$\n\\boxed{\\frac{784071}{80080}}\n$$"
        },
        {
            "introduction": "A thorough evaluation of a propensity score adjustment involves checking multiple diagnostics for balance, weight stability, and covariate overlap. This final exercise synthesizes the concepts from the previous practices into a complete, automated decision-making tool . By implementing this workflow, you will gain practical experience in the holistic assessment required to ensure the reliability of causal estimates in real-world data analysis.",
            "id": "5221137",
            "problem": "You are given summary statistics for multiple covariates in a binary treatment study in medicine, with pre-adjustment (unweighted) and post-adjustment (weighted) summaries after applying a propensity score adjustment. Your task is to build a program that, for each test case, computes covariate balance metrics and weight diagnostics, and then makes a decision among three actions: keep the current adjustment, re-estimate the propensity score function $e(X)$, or switch to an alternative weighting scheme. All computations and decisions must be made using only the provided summaries.\n\nUse a valid base comprising: the definition of the propensity score $e(X)$ as the probability of treatment given covariates, the notion that covariate balance can be assessed by standardized mean differences and variance ratios, and the second-moment identity for computing effective sample size from weights. You must reason from these definitions to construct the algorithm.\n\nCompute for each test case:\n- For each covariate, the post-adjustment standardized mean difference using the standard definition with the pooled standard deviation, and the post-adjustment variance ratio as the ratio of group variances.\n- Weight diagnostics including effective sample size using the second-moment identity, the coefficient of variation of weights based on the first two empirical moments, the maximum observed weight, and a simple overlap diagnostic from the supports of the estimated propensity score in treatment and control groups.\n\nMake a decision following these principles and precise thresholds:\n1) Declare balance acceptable (output code $0$) if and only if simultaneously:\n   - For all covariates, the absolute standardized mean difference is at most $0.1$.\n   - For all covariates, the post-adjustment variance ratio lies within the closed interval $\\left[0.5, 2.0\\right]$.\n   - Weight diagnostics indicate healthy weighting in both groups: each group’s effective sample size fraction is at least $0.5$, each group’s weight coefficient of variation is at most $2.0$, the maximum weight does not exceed $20.0$, the overlap width of the propensity score supports is at least $0.1$, and each group’s propensity score range lies strictly within the interval $\\left[0.01, 0.99\\right]$ (i.e., minimum at least $0.01$ and maximum at most $0.99$).\n2) If condition (1) fails due to covariate imbalance (standardized mean differences or variance ratios outside the acceptable ranges), but the weights are not severely unstable and the overlap is not poor, recommend re-estimation of $e(X)$ (output code $1$).\n3) If there is evidence of severe weight instability or poor overlap, recommend an alternative weighting strategy such as overlap weights, weight truncation, or stabilization (output code $2$). Concretely, declare severity if any of the following holds in either group: effective sample size fraction less than $0.3$, weight coefficient of variation exceeding $3.0$, maximum weight exceeding $30.0$, overlap width less than $0.05$, or a propensity score range that reaches beyond $\\left[0.01, 0.99\\right]$ (i.e., minimum below $0.01$ or maximum above $0.99$).\n\nDefinitions to be implemented from first principles:\n- The standardized mean difference for a covariate is defined using the pooled standard deviation from the two groups.\n- The variance ratio is defined as the ratio of the treated group variance to the control group variance.\n- The effective sample size for a set of nonnegative weights uses the second-moment identity based on the sum of weights and sum of squared weights, and the coefficient of variation uses the empirical first and second moments of the weights.\n- Overlap width is the length of the intersection of the two support intervals of the estimated propensity scores for the treatment and control groups.\n\nInputs for each test case are provided as a tuple of the following items in the exact order:\n- Pre-adjustment group sizes: $n_T$, $n_C$.\n- Pre-adjustment treated means: an array $\\mu_T^{pre}$.\n- Pre-adjustment control means: an array $\\mu_C^{pre}$.\n- Pre-adjustment treated standard deviations: an array $\\sigma_T^{pre}$.\n- Pre-adjustment control standard deviations: an array $\\sigma_C^{pre}$.\n- Post-adjustment treated means: an array $\\mu_T^{post}$.\n- Post-adjustment control means: an array $\\mu_C^{post}$.\n- Post-adjustment treated standard deviations: an array $\\sigma_T^{post}$.\n- Post-adjustment control standard deviations: an array $\\sigma_C^{post}$.\n- Counts of units with nonzero weights: $m_T$, $m_C$.\n- Sum of weights and sum of squared weights in the treated group: $S_T$, $Q_T$.\n- Sum of weights and sum of squared weights in the control group: $S_C$, $Q_C$.\n- Maximum observed weight across all units: $w_{\\max}$.\n- Propensity score support in treated: $p_{\\min,T}$, $p_{\\max,T}$.\n- Propensity score support in control: $p_{\\min,C}$, $p_{\\max,C}$.\n\nYour program must implement the above computations and decision logic exactly and produce, for the provided test suite, a single line of output containing a comma-separated list of integers enclosed in square brackets, where each integer corresponds to one test case in order and is one of $0$, $1$, or $2$ as defined above.\n\nTest suite to hard-code in your program:\n- Test case $1$:\n  - $n_T = 500$, $n_C = 800$.\n  - $\\mu_T^{pre} = [65.0, 0.6, 1.5]$, $\\mu_C^{pre} = [62.0, 0.55, 1.4]$.\n  - $\\sigma_T^{pre} = [10.0, 0.49, 0.70]$, $\\sigma_C^{pre} = [11.0, 0.50, 0.80]$.\n  - $\\mu_T^{post} = [63.0, 0.58, 1.45]$, $\\mu_C^{post} = [63.1, 0.58, 1.46]$.\n  - $\\sigma_T^{post} = [10.5, 0.49, 0.74]$, $\\sigma_C^{post} = [10.6, 0.50, 0.75]$.\n  - $m_T = 500$, $m_C = 800$.\n  - $S_T = 500.0$, $Q_T = 556.0$, $S_C = 800.0$, $Q_C = 914.0$.\n  - $w_{\\max} = 4.0$.\n  - $p_{\\min,T} = 0.05$, $p_{\\max,T} = 0.95$, $p_{\\min,C} = 0.04$, $p_{\\max,C} = 0.96$.\n- Test case $2$:\n  - $n_T = 400$, $n_C = 900$.\n  - $\\mu_T^{pre} = [69.0, 0.62, 1.6]$, $\\mu_C^{pre} = [66.0, 0.56, 1.45]$.\n  - $\\sigma_T^{pre} = [10.0, 0.50, 0.70]$, $\\sigma_C^{pre} = [12.0, 0.50, 0.80]$.\n  - $\\mu_T^{post} = [70.0, 0.60, 1.50]$, $\\mu_C^{post} = [68.0, 0.58, 1.40]$.\n  - $\\sigma_T^{post} = [9.0, 0.50, 0.60]$, $\\sigma_C^{post} = [11.0, 0.50, 0.60]$.\n  - $m_T = 400$, $m_C = 900$.\n  - $S_T = 400.0$, $Q_T = 571.4286$, $S_C = 900.0$, $Q_C = 1285.7143$.\n  - $w_{\\max} = 8.0$.\n  - $p_{\\min,T} = 0.08$, $p_{\\max,T} = 0.92$, $p_{\\min,C} = 0.07$, $p_{\\max,C} = 0.93$.\n- Test case $3$:\n  - $n_T = 200$, $n_C = 1200$.\n  - $\\mu_T^{pre} = [66.0, 0.59, 1.52]$, $\\mu_C^{pre} = [63.5, 0.54, 1.42]$.\n  - $\\sigma_T^{pre} = [10.5, 0.48, 0.72]$, $\\sigma_C^{pre} = [11.2, 0.51, 0.82]$.\n  - $\\mu_T^{post} = [64.0, 0.57, 1.44]$, $\\mu_C^{post} = [64.05, 0.57, 1.45]$.\n  - $\\sigma_T^{post} = [11.0, 0.48, 0.70]$, $\\sigma_C^{post} = [10.8, 0.49, 0.71]$.\n  - $m_T = 200$, $m_C = 1200$.\n  - $S_T = 200.0$, $Q_T = 1000.0$, $S_C = 1200.0$, $Q_C = 4800.0$.\n  - $w_{\\max} = 50.0$.\n  - $p_{\\min,T} = 0.20$, $p_{\\max,T} = 0.95$, $p_{\\min,C} = 0.01$, $p_{\\max,C} = 0.50$.\n\nFinal output format: Your program should produce a single line containing the list of decision codes for the test cases, as a comma-separated list enclosed in square brackets, for example, $[0,1,2]$. The entries must be integers and there must be no spaces.",
            "solution": "The user has provided a problem in the domain of causal inference, specifically concerning the evaluation of propensity score weighting adjustments in observational studies. The task is to implement a decision-making algorithm based on standard diagnostic metrics derived from summary statistics. The problem is scientifically grounded, well-posed, and objective. It contains a minor ambiguity in the definition of a \"healthy\" propensity score range, but provides a clarifying clause which will be followed.\n\nThe solution proceeds by first defining the necessary computational formulas from first principles, and then articulating the precise decision logic that maps the computed diagnostics to one of three recommended actions.\n\n### 1. Diagnostic Metrics Formulation\n\nLet the treated group be denoted by $T$ and the control group by $C$. The initial (pre-adjustment) sample sizes are $n_T$ and $n_C$. The number of units with non-zero weights are $m_T$ and $m_C$. For a given covariate $k$, we are given the pre-adjustment means ($\\mu_{T,k}^{pre}$, $\\mu_{C,k}^{pre}$) and standard deviations ($\\sigma_{T,k}^{pre}$, $\\sigma_{C,k}^{pre}$), as well as their post-adjustment counterparts ($\\mu_{T,k}^{post}$, $\\mu_{C,k}^{post}$, $\\sigma_{T,k}^{post}$, $\\sigma_{C,k}^{post}$).\n\n**1.1. Covariate Balance Metrics**\n\n**Standardized Mean Difference (SMD):** The post-adjustment SMD for covariate $k$ measures the difference in means between the two groups after weighting, scaled by a pooled standard deviation. To provide a stable and consistent scale for comparison, the pooled standard deviation is calculated from the pre-adjustment (unweighted) data. The formula for the pre-adjustment pooled standard deviation for covariate $k$ is:\n$$\n\\sigma_{p,k}^{pre} = \\sqrt{\\frac{(n_T - 1)(\\sigma_{T,k}^{pre})^2 + (n_C - 1)(\\sigma_{C,k}^{pre})^2}{n_T + n_C - 2}}\n$$\nThe post-adjustment SMD is then the absolute difference of the post-adjustment means, standardized by this value:\n$$\n\\text{SMD}_k = \\frac{|\\mu_{T,k}^{post} - \\mu_{C,k}^{post}|}{\\sigma_{p,k}^{pre}}\n$$\n\n**Variance Ratio (VR):** The post-adjustment variance ratio for covariate $k$ assesses the balance in the second moment of the distribution. It is defined as the ratio of the post-adjustment variance of the treated group to that of the control group:\n$$\n\\text{VR}_k = \\frac{(\\sigma_{T,k}^{post})^2}{(\\sigma_{C,k}^{post})^2}\n$$\n\n**1.2. Weight and Overlap Diagnostics**\n\nLet the weights for group $g \\in \\{T, C\\}$ be $\\{w_{g,i}\\}_{i=1}^{m_g}$. The problem provides the sum of weights, $S_g = \\sum_i w_{g,i}$, and the sum of squared weights, $Q_g = \\sum_i w_{g,i}^2$.\n\n**Effective Sample Size (ESS):** The ESS measures the equivalent number of independent observations in the weighted sample, providing an indication of the loss of precision due to weighting. It is calculated using the second-moment identity:\n$$\n\\text{ESS}_g = \\frac{(\\sum_i w_{g,i})^2}{\\sum_i w_{g,i}^2} = \\frac{S_g^2}{Q_g}\n$$\nThe diagnostic metric used in the decision rule is the ESS fraction, which is the ESS relative to the original group size $n_g$:\n$$\n\\text{ESS fraction}_g = \\frac{\\text{ESS}_g}{n_g}\n$$\n\n**Coefficient of Variation (CV) of Weights:** The CV of weights measures their variability. A high CV indicates the presence of a few very large weights, which can lead to unstable estimates. The CV is the ratio of the standard deviation of weights to their mean. The mean weight is $\\bar{w}_g = S_g / m_g$. The variance of weights is $\\sigma_{w,g}^2 = E[w^2] - (E[w])^2 = (Q_g / m_g) - (S_g / m_g)^2$. The CV is therefore:\n$$\n\\text{CV}_g = \\frac{\\sqrt{(Q_g / m_g) - (S_g / m_g)^2}}{S_g / m_g} = \\sqrt{\\frac{Q_g m_g}{S_g^2} - 1}\n$$\n\n**Overlap Width:** This diagnostic assesses the overlap in the distributions of the estimated propensity scores, $e(X)$, between the two groups. Given the support of the propensity scores for the treated group, $[p_{\\min,T}, p_{\\max,T}]$, and the control group, $[p_{\\min,C}, p_{\\max,C}]$, the interval of common support is $[\\max(p_{\\min,T}, p_{\\min,C}), \\min(p_{\\max,T}, p_{\\max,C})]$. The overlap width is the length of this interval, or $0$ if there is no overlap:\n$$\n\\text{Overlap Width} = \\max(0, \\min(p_{\\max,T}, p_{\\max,C}) - \\max(p_{\\min,T}, p_{\\min,C}))\n$$\n\n### 2. Decision Algorithm\n\nThe decision is made by sequentially checking three sets of conditions corresponding to severe problems (code $2$), acceptable outcomes (code $0$), and intermediate issues (code $1$).\n\n**Step 1: Check for Severe Instability (Code 2)**\nThe adjustment is flagged for using an alternative weighting strategy if any of the following severe issues are present:\n-   Effective Sample Size: $\\text{ESS fraction}_T  0.3$ or $\\text{ESS fraction}_C  0.3$.\n-   Weight Variability: $\\text{CV}_T > 3.0$ or $\\text{CV}_C > 3.0$.\n-   Extreme Weight: The maximum weight across all units, $w_{\\max}$, exceeds $30.0$.\n-   Poor Overlap: The Overlap Width is less than $0.05$.\n-   Practical Positivity Violation: The propensity score range extends beyond the interval $[0.01, 0.99]$. That is, $p_{\\min,T}  0.01$ or $p_{\\max,T} > 0.99$ or $p_{\\min,C}  0.01$ or $p_{\\max,C} > 0.99$.\n\nIf any of these conditions are met, the decision is **2**.\n\n**Step 2: Check for Acceptable Balance (Code 0)**\nIf no severe instability is detected, the adjustment is checked for acceptability. The adjustment is deemed acceptable if and only if **all** of the following conditions related to both balance and weight health are met:\n-   Covariate Balance:\n    -   Mean Balance: For all covariates $k$, $\\text{SMD}_k \\le 0.1$.\n    -   Variance Balance: For all covariates $k$, $0.5 \\le \\text{VR}_k \\le 2.0$.\n-   AND Healthy Weighting:\n    -   Effective Sample Size: $\\text{ESS fraction}_T \\ge 0.5$ and $\\text{ESS fraction}_C \\ge 0.5$.\n    -   Weight Variability: $\\text{CV}_T \\le 2.0$ and $\\text{CV}_C \\le 2.0$.\n    -   Extreme Weight: $w_{\\max} \\le 20.0$.\n    -   Sufficient Overlap: The Overlap Width is at least $0.1$.\n    -   Propensity Score Range: Both score ranges lie within $[0.01, 0.99]$. Specifically, $p_{\\min,g} \\ge 0.01$ and $p_{\\max,g} \\le 0.99$ for both groups $g \\in \\{T, C\\}$.\n\nIf all of these conditions hold, the decision is **0**.\n\n**Step 3: Recommend Re-estimation (Code 1)**\nIf the adjustment does not exhibit severe instability (Step 1 fails) but also does not meet the criteria for acceptability (Step 2 fails), it falls into an intermediate category. This typically occurs when covariate balance is not achieved, but the weights themselves are not excessively volatile. In this case, re-specifying the propensity score model is recommended. The decision is **1**.",
            "answer": "```python\nimport numpy as np\n\ndef solve():\n    \"\"\"\n    Solves the propensity score evaluation problem for a suite of test cases.\n    \"\"\"\n    test_cases = [\n        # Test case 1\n        (500, 800,  # n_T, n_C\n         np.array([65.0, 0.6, 1.5]), np.array([62.0, 0.55, 1.4]),  # mu_T_pre, mu_C_pre\n         np.array([10.0, 0.49, 0.70]), np.array([11.0, 0.50, 0.80]),  # sigma_T_pre, sigma_C_pre\n         np.array([63.0, 0.58, 1.45]), np.array([63.1, 0.58, 1.46]),  # mu_T_post, mu_C_post\n         np.array([10.5, 0.49, 0.74]), np.array([10.6, 0.50, 0.75]),  # sigma_T_post, sigma_C_post\n         500, 800,  # m_T, m_C\n         500.0, 556.0, 800.0, 914.0,  # S_T, Q_T, S_C, Q_C\n         4.0,  # w_max\n         0.05, 0.95, 0.04, 0.96),  # p_min_T, p_max_T, p_min_C, p_max_C\n        # Test case 2\n        (400, 900,\n         np.array([69.0, 0.62, 1.6]), np.array([66.0, 0.56, 1.45]),\n         np.array([10.0, 0.50, 0.70]), np.array([12.0, 0.50, 0.80]),\n         np.array([70.0, 0.60, 1.50]), np.array([68.0, 0.58, 1.40]),\n         np.array([9.0, 0.50, 0.60]), np.array([11.0, 0.50, 0.60]),\n         400, 900,\n         400.0, 571.4286, 900.0, 1285.7143,\n         8.0,\n         0.08, 0.92, 0.07, 0.93),\n        # Test case 3\n        (200, 1200,\n         np.array([66.0, 0.59, 1.52]), np.array([63.5, 0.54, 1.42]),\n         np.array([10.5, 0.48, 0.72]), np.array([11.2, 0.51, 0.82]),\n         np.array([64.0, 0.57, 1.44]), np.array([64.05, 0.57, 1.45]),\n         np.array([11.0, 0.48, 0.70]), np.array([10.8, 0.49, 0.71]),\n         200, 1200,\n         200.0, 1000.0, 1200.0, 4800.0,\n         50.0,\n         0.20, 0.95, 0.01, 0.50)\n    ]\n\n    results = []\n    for case in test_cases:\n        decision = analyze_adjustment(*case)\n        results.append(decision)\n\n    print(f\"[{','.join(map(str, results))}]\")\n\ndef analyze_adjustment(n_T, n_C, mu_T_pre, mu_C_pre, sigma_T_pre, sigma_C_pre,\n                         mu_T_post, mu_C_post, sigma_T_post, sigma_C_post,\n                         m_T, m_C, S_T, Q_T, S_C, Q_C, w_max,\n                         p_min_T, p_max_T, p_min_C, p_max_C):\n    \"\"\"\n    Computes diagnostics and returns a decision code (0, 1, or 2).\n    \"\"\"\n    \n    # 1. Compute Covariate Balance Metrics\n    var_T_pre = sigma_T_pre**2\n    var_C_pre = sigma_C_pre**2\n    pooled_sd_pre = np.sqrt(((n_T - 1) * var_T_pre + (n_C - 1) * var_C_pre) / (n_T + n_C - 2))\n    \n    smds = np.abs(mu_T_post - mu_C_post) / pooled_sd_pre\n    \n    var_T_post = sigma_T_post**2\n    var_C_post = sigma_C_post**2\n    vrs = var_T_post / var_C_post\n\n    # 2. Compute Weight and Overlap Diagnostics\n    ess_T = S_T**2 / Q_T if Q_T > 0 else 0\n    ess_C = S_C**2 / Q_C if Q_C > 0 else 0\n    ess_frac_T = ess_T / n_T\n    ess_frac_C = ess_C / n_C\n    \n    cv_T = np.sqrt((Q_T * m_T / S_T**2) - 1) if S_T > 0 else float('inf')\n    cv_C = np.sqrt((Q_C * m_C / S_C**2) - 1) if S_C > 0 else float('inf')\n    \n    overlap_min = max(p_min_T, p_min_C)\n    overlap_max = min(p_max_T, p_max_C)\n    overlap_width = max(0, overlap_max - overlap_min)\n    \n    # 3. Apply Decision Logic\n    # Check for severe instability (Code 2)\n    severe_instability = (\n        ess_frac_T  0.3 or ess_frac_C  0.3 or\n        cv_T > 3.0 or cv_C > 3.0 or\n        w_max > 30.0 or\n        overlap_width  0.05 or\n        p_min_T  0.01 or p_max_T > 0.99 or\n        p_min_C  0.01 or p_max_C > 0.99\n    )\n    if severe_instability:\n        return 2\n        \n    # Check for acceptable balance (Code 0)\n    balance_ok = np.all(smds = 0.1) and np.all(vrs >= 0.5) and np.all(vrs = 2.0)\n    \n    weights_healthy = (\n        ess_frac_T >= 0.5 and ess_frac_C >= 0.5 and\n        cv_T = 2.0 and cv_C = 2.0 and\n        w_max = 20.0 and\n        overlap_width >= 0.1 and\n        p_min_T >= 0.01 and p_max_T = 0.99 and\n        p_min_C >= 0.01 and p_max_C = 0.99\n    )\n\n    if balance_ok and weights_healthy:\n        return 0\n    \n    # Otherwise, recommend re-estimation (Code 1)\n    return 1\n\nsolve()\n\n```"
        }
    ]
}